ニュース

FDA approves Novavax's COVID-19 vaccine with limitations
The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.
Infectious Disease Advisor4 時間
FDA Approves Novavax’s COVID-19 Vaccine Nuvaxovid
The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years ...
FDA approves Novavax COVID-19 shot but with unusual restrictions
The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual ...
After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those ...
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine
Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...
Novavax Stock Soars on FDA Approval for New COVID-19 Vaccine
Novavax received Food and Drug Administration approval for its new, protein-based COVID-19 vaccine, and shares jumped 25% at ...
Novavax jumps as FDA clears COVID-19 vaccine
Novavax (NVAX) shares climbed more than 17% premarket on Monday after the long-delayed approval of its COVID-19 vaccine from ...
PharmExec1 日
FDA Grants Full Approval to Novavax’s Nuvaxovid COVID-19 Vaccine
Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.
FDA may limit future COVID-19 boosters to seniors, those at higher risk for complications
US Food and Drug Administration officials are changing the agency's standards for updated COVID-19 booster shots with focus ...
Stocktwits on MSN2 日
Novavax Stock Rips Nearly 20% Pre-Market After FDA Approves Its COVID-19 Vaccine Nuvaxovid
Pharmaceutical giant Novavax on Monday announced that the U.S. Food and Drug Administration (FDA) approved its COVID-19 ...
Healio1 日
FDA approves Novavax’s COVID-19 vaccine — with restrictions
The FDA has approved Novavax’s protein-based COVID-19 vaccine, giving some Americans another option besides messenger RNA vaccines to prevent SARS-CoV-2 infection.